Therapeutic drug monitoring of TNFα inhibitors: a spotlight on novel techniques and assays

Click to increase image sizeClick to decrease image size

Declaration of interest

D Cattaneo has received fees for presentations at meetings/workshops and/or travel grants from Merck Sharp & Dome, Gilead, Janssen Cilag, ViiV Healthcare, and Siemens Healthineers. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Additional information

Funding

This paper was not funded.